Israeli startup CytoReason, maker of a computation model to map and compare treatments, announced it secured $80 million in funding.
Pfizer, OurCrowd, NVIDIA and Thermo Fisher Scientific participated in the round.
WHAT IT DOES
CytoReason offers life sciences companies AI-enabled tools to gather data-driven and molecular-level insights to improve phase 2 success in clinical trials and optimize...
Courier Health, a health tech company for life sciences manufacturers, announced it scored $16.5 million in Series A funding.
Norwest Venture Partners led the round with participation from existing investor Work-Bench.
WHAT IT DOES
The New York-based company offers biopharma commercial teams with a customer relationship management (CRM) system to understand the complete patient journey, analyze...
Antidote Technologies, a digital patient engagement company, announced it is partnering with SEQSTER, a multidimensional healthcare data platform, to identify patients for clinical trials and improve trial timelines.
Antidote offers a clinical trial patient-recruitment platform that includes patient screening and support services.
The company will leverage SEQSTER's operating system to better...
Amazon Web Services (AWS) announced that it is collaborating with EvolutionaryScale, an AI company focused on biology, to give scientists and researchers access to the startup's ESM3 language models via AWS to advance drug discovery by allowing for the creation of new proteins.
Yesterday, EvolutionaryScale, founded by former researchers at Meta’s AI research lab, announced it secured $142 million...
New AI helps lower cost of drug discovery
Australian researchers have created a new drug discovery AI tool for decoding protein-molecule interactions without the need for rendering costly 3D structures.
Their drug discovery model called PSICHIC (PhySIcoCHemICal) uses AI to identify unique "fingerprints" of specific protein-molecule interactions from sequence data.
PSICHIC was able to "...
Google Research and Google DeepMind recently released a paper announcing the creation of a new LLM for drug discovery and therapeutic development dubbed Tx-LLM, fine-tuned from PaLM-2.
Tx-LLM utilizes the tech giant's PaLM-2, its generative AI technology that uses Google's LLMs to answer medical questions.
The drug discovery-focused LLM was trained using 709 datasets to target 66 tasks across...
The founder and CEO and the clinical president of digital healthcare company Done Health, which provides psychiatric chronic care management, were arrested Thursday for allegedly participating in a scheme to distribute Adderall online, and for obstructing justice and conspiring to commit fraud.
According to the Justice Department, California-based Done Global's founder and CEO, Ruthia He, and...
San Francisco-based Plenful, a workflow-automation platform for pharmacy and healthcare operations, announced it secured $17 million in Series A investment less than a year after launching with $9 million in funding.
TQ Ventures led the round, with participation from Mitchell Rales (cofounder and chairman of Danaher), Susa Ventures and existing investors.
WHAT IT DOES
Plenful offers pharmacy...
Telstra Health is set to fully acquire pharmacy IT solutions provider Fred IT Group.
The company, which has been holding 50% interest in Fred IT since 2013, disclosed in a media release that it will be purchasing the remaining half of equity from the Victoria branch of the Pharmacy Guild of Australia and Paul Naismith, Fred IT co-founder and CEO.
Upon the close of the transaction, Naismith will...
Direct-to-consumer virtual care company Hims & Hers is the latest digital health company to announce it will add GLP-1 medications to its offerings to assist users with weight-loss management.
The San Francisco-based company, which launched its weight-loss program in December, said users will now have access to generic and 503B compounded injectable medications and oral medication kits...
